8866
L. Xu, T. D. Lash / Tetrahedron Letters 47 (2006) 8863–8866
Graham, S. R.; Ferrence, G. M.; Szczepura, L. F. Inorg.
Chem. 2003, 42, 7326.
11. (a) Muckey, M. A.; Szczepura, L. F.; Ferrence, G. M.;
Lash, T. D. Inorg. Chem. 2002, 41, 4840; (b) Lash, T. D.;
Colby, D. A.; Szczepura, L. F. Inorg. Chem. 2004, 43,
5258.
12. Lash, T. D.; Rasmussen, J. M.; Bergman, K. M.; Colby,
D. A. Org. Lett. 2004, 6, 549.
13. Bergman, K. M.; Ferrence, G. M.; Lash, T. D. J. Org.
Chem. 2004, 69, 7888.
14. (a) Hayes, M. J.; Spence, J. D.; Lash, T. D. Chem.
Commun. 1998, 2409; (b) Lash, T. D.; Muckey, M. A.;
Hayes, M. J.; Liu, D.; Spence, J. D.; Ferrence, G. M. J.
Org. Chem. 2003, 68, 8558.
15. Kamowski, E. M.; Passini, J.; Jones, M. A. ; Lash, T. D.
Book of Abstracts for the 227th National ACS Meeting,
Anaheim CA, 2004, MEDI 58.
16. Lash, T. D.; Romanic, J. L.; Hayes, M. J.; Spence, J. D.
Chem. Commun. 1999, 819.
17. Graham, S. R.; Colby, D. A.; Lash, T. D. Angew. Chem.,
Int. Ed. 2002, 41, 1371.
MeOH–CHCl3): kmax (log10 e) 368 (4.41), 451 (4.91), 557
(3.95), 602 (4.26), 713 nm (3.29); UV–vis (5% Et3N in 50/
50 MeOH–CHCl3): kmax (log10 e) 376 (4.53), 450 (4.90),
544 (4.00), 593 nm (4.13); UV–vis (1% TFA in 50/50
MeOH–CHCl3): kmax (log10 e) 368 (4.35), 465 (4.83), 531
(3.71), 574 (4.00), 622 nm (4.51); IR (KBr): m 3430 (mOH),
1594 cmꢀ1 (mC@O); 1H NMR (DMSO-d6): d ꢀ5.13 (1H, s),
ꢀ4.84 (1H, s), ꢀ1.92 (1H, s), ꢀ1.54 (1H, s), 1.58 (6H, m),
3.3 (6H, s, obscured by solvent), 3.78 (4H, m), 7.62 (2H,
m), 7.9 (1H, br), 8.77 (2H, m), 9.56 (1H, s), 9.70 (1H, s),
9.98 (1H, s), 10.02 (1H, s), 10.42 (1H, s); 1H NMR (TFA–
DMSO-d6): d ꢀ4.92 (1H, s), ꢀ4.64 (1H, s), ꢀ1.49 (2H, s),
1.57 (6H, t, J = 7.4 Hz), 3.31 (6H, s), 3.76 (4H, q,
J = 7.2 Hz), 7.62 (2H, m), 7.9 (1H, obscured by solvent),
8.75 (2H, m), 9.58 (2H, s), 9.96 (2H, s); 1H NMR
(pyridine-d5): d ꢀ4.26 (1H, s), ꢀ4.05 (1H, s), ꢀ1.65 (2H,
s), 1.55 (6H, t, J = 7.4 Hz), 3.22 (6H, s), 3.75 (4H, q,
J = 7.6 Hz), 7.82–7.85 (2H, m), 8.94–8.98 (2H, m), 9.90
(2H, s), 10.83 (2H, s); HRMS (FAB): Calcd for
C33H30N2O2: 486.2307. Found 486.2306.
8,19-Diethyl-4-hydroxy-3,9,18-trimethyl-24-carbabenzo[m]-
oxybenziporphyrin (11b). Using the foregoing procedure,
methylresorcinol tripyrrane analogue 9b (75.0 mg) was
reacted with indene dialdehyde 10 (28.4 mg). Following
evaporation of the solvent, the residue was recrystallized
from methanol and then chloroform–methanol to give 11b
(14.8 mg; 18%) as a brown powder, mp>300 °C; UV–vis
(DMSO): kmax (log10 e) 377 (4.56), 451 (4.77), 523 (4.32),
595 (4.28), 719 (3.75), 778 nm (3.48); UV–vis (10% TFA–
DMSO): kmax (log10 e) 453 (4.70), 468 (4.70), 521 (4.27),
579 (4.20), 626 nm (4.37); IR (KBr): m 3425 (mOH),
1595 cmꢀ1 (mC@O); 1H NMR (DMSO-d6): d ꢀ5.11 (1H,
s), ꢀ4.82 (1H, s), ꢀ1.89 (1H, s), ꢀ1.52 (1H, s), 1.60 (6H,
m), 2.44 (3H, s), 3.31 (6H, s), 3.80 (4H, m), 7.63 (2H, m),
8.77 (2H, m), 9.56 (1H, s), 9.70 (1H, s), 9.98 (1H, s), 10.02
(1H, s), 10.42 (1H, s); 1H NMR (TFA–DMSO-d6): d
ꢀ4.89 (1H, s), ꢀ4.61 (1H, s), ꢀ1.46 (2H, s), 1.57 (6H, t,
J = 7.4 Hz), 2.42 (3H, s), 3.31 (6H, s), 3.76 (4H, q,
J = 7.2 Hz), 7.62 (2H, m), 8.75 (2H, m), 9.57 (2H, s), 9.95
(2H, s); 1H NMR (pyridine-d5): d ꢀ4.24 (1H, s), ꢀ3.99
(1H, s), ꢀ1.50 (2H, s), 1.54 (6H, t, J = 7.4 Hz), 3.10 (3H,
s), 3.23 (6H, s), 3.75 (4H, q, J = 7.6 Hz), 9.87 (2H, s),
10.85 (2H, s) (benzo-protons obscured by solvent); 13C
NMR (TFA–DMSO-d6): d 10.7, 11.4, 17.4, 19.7, 98.2,
104.6, 112.3, 113.5, 115.0, 120.7, 121.5, 127.4, 130.8, 134.5,
136.3, 141.6, 142.2, 175.3; HRMS (FAB): Calcd for
C34H32N2O2: 500.2464. Found 500.2464.
18. (a) Araki, K.; Winnischofer, H.; Toma, H. E.; Maeda, H.;
Osuka, A.; Furuta, H. Inorg. Chem. 2001, 40, 2020; (b)
Ogawa, T.; Furuta, H.; Morino, A.; Takahashi, M.; Uno,
H. Organomet. Chem. 2000, 611, 551.
19. Maeda, H.; Osuka, A.; Furuta, H. J. Am. Chem. Soc.
2003, 125, 15690.
20. (a) Furuta, H.; Ogawa, T.; Uwatoko, Y.; Araki, K. Inorg.
Chem. 1999, 38, 2676; (b) Furuta, H.; Maeda, H.; Osuka,
A. Chem. Commun. 2002, 1795.
21. Miyake, K.; Lash, T. D. Chem. Commun. 2004, 178.
22. Arnold, Z. Collect. Czech. Chem. Commun. 1965, 30, 2783.
23. 8,19-Diethyl-4-hydroxy-9,18-dimethyl-24-carbabenzo[m]oxy-
benziporphyrin (11a). Resorcinol tripyrrane analogue 9a
(75.0 mg) was stirred under nitrogen with TFA (1 mL) in a
250 mL pear shaped flask for 2 min. Dichloromethane
(200 mL) was added, followed immediately by diformyl
indene 10 (29.3 mg), and the resulting mixture stirred in
the dark under nitrogen for 16 h. The mixture was shaken
with 0.1% w/v aqueous ferric chloride solution (200 mL)
for 5 min, and then washed with water, sodium bicarbon-
ate solution and water. The aqueous phases were back
extracted with chloroform at each stage. The solvent was
removed under reduced pressure and the resulting brown
residue recrystallized from methanol and then chloro-
form–methanol to give the dicarbaporphyrin (20.3 mg,
25%) as a dark purple powder, mp >300 °C; UV–vis (50%